CureVac NV (CVAC)
3.13
+0.36
(+13.00%)
USD |
NASDAQ |
May 03, 16:00
3.13
0.00 (0.00%)
After-Hours: 20:00
CureVac Debt to Equity Ratio: 0.00 for Dec. 31, 2023
Debt to Equity Ratio Chart
Historical Debt to Equity Ratio Data
Date | Value |
---|---|
December 31, 2023 | 0.00 |
September 30, 2023 | 0.00 |
June 30, 2023 | 0.00 |
March 31, 2023 | 0.00 |
December 31, 2022 | 0.00 |
September 30, 2022 | 0.00 |
June 30, 2022 | 0.00 |
March 31, 2022 | 0.00 |
December 31, 2021 | 0.00 |
Date | Value |
---|---|
September 30, 2021 | 0.0396 |
June 30, 2021 | 0.00 |
March 31, 2021 | |
December 31, 2020 | 0.00 |
September 30, 2020 | 0.00 |
June 30, 2020 | |
March 31, 2020 | -1.536 |
December 31, 2019 | -1.519 |
Debt to Equity Ratio Definition
The debt to equity ratio measures the (Long Term Debt + Current Portion of Long Term Debt) / Total Shareholders' Equity. This metric is useful when analyzing the health of a company's balance sheet.
Debt to Equity Ratio Range, Past 5 Years
-1.536
Minimum
Mar 2020
0.0396
Maximum
Sep 2021
-0.2011
Average
--
Median
Sep 2020
Debt to Equity Ratio Benchmarks
Affimed NV | 0.2102 |
InflaRx NV | 0.00 |
MorphoSys AG | 12.71 |
BioNTech SE | 0.0108 |
Immatics NV | 0.00 |
Debt to Equity Ratio Related Metrics
Total Assets (Quarterly) | 871.33M |
Total Liabilities (Quarterly) | 299.90M |
Shareholders Equity (Quarterly) | 571.43M |
Current Ratio | 2.567 |